$3.74
0.010.27%
Últ. Act.: Oct 21, 4:00 PM
$3.74
0.010.27%
Immuneering (IMRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.27 | $-0.26 | $-0.31 | $-0.38 |
| Actual | $-0.27 | $-0.21 | $-0.18 | $-0.38 |
| Surprise | 0.00% | +19.2% | +41.9% | 0.00% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | — | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.30 | $-0.33 | $-0.35 | $-0.37 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.27 | $-0.27 | 0.00 % |
| Q1 | May 15, 2026 | $-0.21 | $-0.26 | 19.2 % |
| Q4 | Mar 6, 2026 | $-0.18 | $-0.31 | 41.9 % |
| Q3 | Nov 12, 2025 | $-0.38 | $-0.38 | 0.00 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q1 | May 4, 2023 | $0 | $10.00K | -100.0 % |
| Q4 | Mar 6, 2023 | $456.00 | $60.00K | -99.2 % |
| Q3 | Nov 10, 2022 | $38.38K | $150.00K | -74.4 % |
| Q2 | Aug 10, 2022 | $94.42K | $180.00K | -47.5 % |